MANIFESTATIONS OF THE COVID-19 EPIDEMIC: INSIGHTS FROM A CONTINUOUS RETROSPECTIVE OBSERVATIONAL STUDY

УДК 616.988:578.843.1:615.371

Authors

  • Maya I. Bandatskaya Belarusian State Medical University, Minsk, Republic of Belarus https://orcid.org/0009-0003-4362-9247 Email: maiyaband@mail.ru
  • Elena O. Samoilovich Republican Scientific and Practical Center of Epidemiology and Microbiology, Minsk, Republic of Belarus Email: esamoilovich@gmail.com
  • Alina M. Dronina Republican Scientific and Practical Center of Epidemiology and Microbiology, Minsk, Republic of Belarus Email: alinadronina@mail.ru
  • Victor V. Franchuk City Polyclinic No. 28, Minsk, Republic of Belarus Email: 28gp@mail.ru
  • Larisa G. Kazak City Polyclinic No. 28, Minsk, Republic of Belarus Email: 28gp@mail.ru

DOI:

https://doi.org/10.31684/25418475-2024-1-22

Keywords:

new coronavirus infection, recurrent COVID-19 cases, cohort study, incidence rate

Abstract

Introduction. Observational evaluations of vaccination effectiveness, particularly cohort studies, are hindered by differences in key characteristics between vaccinated and unvaccinated cohorts, leading to systematic errors. Hence, careful design and consideration of the specific epidemic process in a given setting are essential in assessing vaccination effectiveness. Aim. The study aimed to establish the manifestations of the COVID-19 epidemic process necessary for subsequent evaluation of COVID-19 vaccination efficacy in real-life settings. Materials and Methods. A continuous observational retrospective study was conducted to investigate the structure, dynamics, and COVID-19 morbidity rates of the adult population of Minsk, served by one of the polyclinics, from April 2020 to March 2023, using outpatient medical records (Form 025/u-07). Results. Seven waves of COVID-19 incidence, varying in level and circulating virus variants, were identified over 5-6 month periods. The frequency of recurrent COVID-19 cases was 8.3%, with the highest frequency observed during the 5th wave, coinciding with the arrival of the SARS-CoV-2 omicron variant. Incidence rates of recurrent cases were 6.7 cases per 100 persons per wave, 24% lower than the general population's incidence rate (8.8 cases per 100 persons per wave) (p<0.05). Statistically significant differences in incidence rates between age groups were observed, reaching 14.2 cases per 100 people per year, or 2.6 times higher. Conclusions. When assessing vaccination efficacy in real-life cohort studies, it is advisable to calculate rates separately for each COVID-19 wave. During the fifth and subsequent waves, the risk of COVID-19 development and other outcomes characterizing severity and consequences of infection should be considered. Differences in incidence rates between age groups necessitate stratification of compared groups by age and sex.

Downloads

Download data is not yet available.

Author information

Maya I. Bandatskaya,
Belarusian State Medical University, Minsk, Republic of Belarus

Cand. Sci. (Med.), Associate Professor, Department of Epidemiology, Belarusian State Medical University, Minsk, Republic of Belarus.
E-mail: maiyaband@mail.ru
https://orcid.org/0009-0003-4362-9247

Elena O. Samoilovich,
Republican Scientific and Practical Center of Epidemiology and Microbiology, Minsk, Republic of Belarus

Dr. Sci. (Med.), Professor, Head of the Laboratory of Vaccine-Mediated Infections, Republican Scientific and Practical Center of Epidemiology and Microbiology, Minsk, Republic of Belarus.
E-mail: esamoilovich@gmail.com

Alina M. Dronina,
Republican Scientific and Practical Center of Epidemiology and Microbiology, Minsk, Republic of Belarus

Cand. Sci. (Med.), Associate Professor, Deputy Director for Research, Republican Scientific and Practical Center of Epidemiology and Microbiology, Minsk, Republic of Belarus.
E-mail: alinadronina@mail.ru

Victor V. Franchuk,
City Polyclinic No. 28, Minsk, Republic of Belarus

Medical Statistician, City Polyclinic No. 28, Minsk, Republic of Belarus.
E-mail: 28gp@mail.ru

Larisa G. Kazak,
City Polyclinic No. 28, Minsk, Republic of Belarus

Cand. Sci. (Med.), Associate Professor, Chief Physician, City Polyclinic No. 28, Minsk, Republic of Belarus.
E-mail: 28gp@mail.ru

References

  • World Health Organization. Evaluation of COVID-19 vaccine effectiveness: interim guidance, 17 March 2021. World Health Organization, 2021. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccine_effectiveness-measurement-2021.1
  • Albom A., Norell S. Introduction to modern epidemiology / translated from English. Tallinn, 1996: 121. (In Russ.)
  • Dashkevich A.M., Kolomiets N.D., Vysotskaya V.S. et al. Current epidemiological situation of COVID-19 in the Republic of Belarus: characteristics of the epidemic process, sanitary and anti-epidemic measures. 2022 medRxiv. Available at: https://www.medrxiv.org/content/10.1101/2022.03.10.22271815v1. https://doi.org/10.1101/2022.03.10.22271815
  • Gasich E.L., Bulda K.Yu, Drozd A.M. et al. Application of modern technologies for molecular genetic tracking of the spread of the causative agent of the new coronavirus infection SARS-CoV-2 and forecasting the development of the epidemic COVID-19. Biological security of the Republic of Belarus: national interests, threats, strategic directions of provision, assessment of the state: tr. scientific and practical conference, Minsk, December 8, 2021. Novosti mediko-biologicheskikh nauk. 2021; 4: 76-84. (In Russ.)
  • Andrews N., Stowe J., Kirsebom F. et al. Covid-19 vaccine effectiveness against the Omicron (B. 1.1. 529) variant. New England Journal of Medicine. 2022; 386:1532-1546. https://doi.org/10.1056/NEJMoa2119451
  • Published

    2024-03-25

    How to Cite

    Bandatskaya M. I., Samoilovich E. O., Dronina A. M., Franchuk V. V., Kazak L. G. MANIFESTATIONS OF THE COVID-19 EPIDEMIC: INSIGHTS FROM A CONTINUOUS RETROSPECTIVE OBSERVATIONAL STUDY: УДК 616.988:578.843.1:615.371 // Bulletin of Medical Science, 2024. Vol. 33, № 1. P. 22–28 DOI: 10.31684/25418475-2024-1-22. URL: https://newbmn.asmu.ru/bmn/article/view/660.